These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10812762)

  • 21. Complementary and alternative medicine. The daunting challenge.
    Brown E
    Physician Exec; 1998; 24(6):16-21. PubMed ID: 10351710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient visits to a hospital-based alternative medicine clinic from 1997 through 2002: experience from an integrated healthcare system.
    Bracha Y; Svendsen K; Culliton P
    Explore (NY); 2005 Jan; 1(1):13-20. PubMed ID: 16781496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
    Führlinger S
    Wien Med Wochenschr; 2006 Dec; 156(23-24):612-8. PubMed ID: 17211765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic analysis of complementary medicine: a systematic review.
    White AR; Ernst E
    Complement Ther Med; 2000 Jun; 8(2):111-8. PubMed ID: 10859604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complementary and alternative medicine: opportunities and challenges.
    Martin WM; Long HW
    J Health Care Finance; 2007; 34(2):89-104. PubMed ID: 18972997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insurance coverage and subsequent utilization of complementary and alternative medicine providers.
    Lafferty WE; Tyree PT; Bellas AS; Watts CA; Lind BK; Sherman KJ; Cherkin DC; Grembowski DE
    Am J Manag Care; 2006 Jul; 12(7):397-404. PubMed ID: 16834526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Motivation for the choice of complementary and mainstream medicine. Patients' behavior in a pluralistic medical system].
    Schär A; Messerli-Rohrbach V
    Forsch Komplementarmed; 1999 Feb; 6 Suppl 1():10-3. PubMed ID: 10077707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cost-effectiveness of new drugs impacts reimbursement decision making but room for improvement].
    Hoomans T; van der Roer N; Severens JL; Delwel GO
    Ned Tijdschr Geneeskd; 2010; 154():A958. PubMed ID: 20699045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Preventive medicine: costs and responsibilities of insurance companies].
    Brunner HH
    Praxis (Bern 1994); 1998 Jan; 87(3):57-60, 62-3. PubMed ID: 9492587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of complementary and alternative medicine by patients with cancer in northern Turkey: analysis of cost and satisfaction.
    Aydin Avci I; Koç Z; Sağlam Z
    J Clin Nurs; 2012 Mar; 21(5-6):677-88. PubMed ID: 21714820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Place of Complementary Medicine in Switzerland's future Healthcare].
    Frei-Erb M
    Rev Med Suisse; 2012 Jan; 8(325):213-4. PubMed ID: 22338521
    [No Abstract]   [Full Text] [Related]  

  • 33. Current trends in the integration and reimbursement of complementary and alternative medicine by managed care, insurance carriers, and hospital providers.
    Pelletier KR; Marie A; Krasner M; Haskell WL
    Am J Health Promot; 1997; 12(2):112-22. PubMed ID: 10174663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Complementary medicine and health legislation].
    Künzi M
    Forsch Komplementarmed; 1999 Feb; 6 Suppl 1():14-6. PubMed ID: 10077708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Communication of potential benefits and harm to patients and payers in psychiatry: a review and commentary.
    Wu R; Kemp DE; Sajatovic M; Zhao J; Calabrese JR; Gao K
    Clin Ther; 2011 Dec; 33(12):B62-76. PubMed ID: 22177380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complementary and alternative medicine in asthma--safety, effectiveness and costs.
    Brutsche MH
    Swiss Med Wkly; 2002 Jun; 132(25-26):329-31. PubMed ID: 12422288
    [No Abstract]   [Full Text] [Related]  

  • 37. Policy on third-party reimbursement of medical fees related to sedation/general anesthesia for delivery of oral health services.
    ;
    Pediatr Dent; 2008-2009; 30(7 Suppl):74-5. PubMed ID: 19216395
    [No Abstract]   [Full Text] [Related]  

  • 38. Review of economic methods used in complementary medicine.
    Doran CM; Chang DH; Kiat H; Bensoussan A
    J Altern Complement Med; 2010 May; 16(5):591-5. PubMed ID: 20804369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Criteria for assessing benefit with complementary medical methods].
    Heusser P
    Forsch Komplementarmed Klass Naturheilkd; 2001 Feb; 8(1):14-23. PubMed ID: 11340310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk selection and complementary health insurance: the Swiss approach.
    Kifmann M
    Int J Health Care Finance Econ; 2006 Jun; 6(2):151-70. PubMed ID: 16783507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.